CRC development is primarily driven by disruptions in core signaling pathways in epithelial cells, notably the aberrant activation of WNT and EGFR and the concurrent suppression of the TGFβ-BMP axis14,65. The gene discussed is TGFB1; the disease is colorectal carcinoma.